T cells

Scientists isolate rare yet desirable CAR T cell subtypes using an innovative cell sorter system within a closed manufacturing process.

With advancements in electroporation systems, researchers have better options for introducing nucleic acids into cells.

A study finds that T cells induced by heroin cross the blood-brain barrier to wreak havoc on the brain, hinting at new ways to prevent withdrawal.

Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.

Learn about the tools and resources researchers use to define, discover, and deploy anti-tumor immunotherapies.

Closed systems increase cell therapy manufacturing process efficiency.

Pregnancy-induced changes in the immune system are key to a successful birth. Understanding those changes could allow researchers to protect both mother and child.

Aberrant immune activation, the main cause of prematurity and stillbirths, could be preventable through interventions such as maternal vaccination. 

Staphylococcus aureus appears to be the culprit.

New single cell technologies make previously unattainable discoveries a reality.

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

Scientists discover tumor-associated T cells that drive breast cancer metastasis to lymph nodes.

Researchers report that vaccination against proteins found on profibrotic cells reduced liver and lung fibrosis in laboratory rodents.

How a flexible large-volume electroporation solution can improve transfection efficiency.

Monitor cell health throughout drug development for optimized cell-based therapeutics.

Researchers have an exclusive opportunity to test their samples using a next-generation spatial -omics instrument.

Access to single cell resolution reveals new insights into how the human body and its cells operate during health and disease.

For the first time, researchers performed a head-to head longitudinal study comparing the immune response elicited by mRNA and traditional COVID-19 vaccines to primary infections.

Scientists discovered a possibly autoreactive T cell population that forecasts and supports disease progression.

Commerically-available peripheral blood mononuclear cells offer a well-characterized, accessible, and consistent model for immunology and therapeutic development.